BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23529167)

  • 21. Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.
    Matsuda M; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Uneda K; Haku S; Tsurumi-Ikeya Y; Toya Y; Maeshima Y; Yamashita A; Umemura S
    J Biol Chem; 2013 Jun; 288(26):19238-49. PubMed ID: 23653383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function.
    Tamura K; Tanaka Y; Tsurumi Y; Azuma K; Shigenaga A; Wakui H; Masuda S; Matsuda M
    Curr Hypertens Rep; 2007 Apr; 9(2):121-7. PubMed ID: 17442223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II-Induced Hypertension.
    Shao S; Li XD; Lu YY; Li SJ; Chen XH; Zhou HD; He S; Guo YT; Lu X; Gao PJ; Wang JG
    Hypertension; 2021 Mar; 77(3):868-881. PubMed ID: 33486984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
    Tamura K; Wakui H; Maeda A; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Haku S; Uneda K; Masuda S; Azuma K; Shigenaga A; Koide Y; Tsurumi-Ikeya Y; Matsuda M; Toya Y; Tokita Y; Yamashita A; Umemura S
    Curr Pharm Des; 2013; 19(17):3043-8. PubMed ID: 23176217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization.
    Haruhara K; Suzuki T; Wakui H; Azushima K; Kurotaki D; Kawase W; Uneda K; Kobayashi R; Ohki K; Kinguchi S; Yamaji T; Kato I; Ohashi K; Yamashita A; Tamura T; Tsuboi N; Yokoo T; Tamura K
    Kidney Int; 2022 May; 101(5):912-928. PubMed ID: 35240129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension.
    Norlander AE; Saleh MA; Kamat NV; Ko B; Gnecco J; Zhu L; Dale BL; Iwakura Y; Hoover RS; McDonough AA; Madhur MS
    Hypertension; 2016 Jul; 68(1):167-74. PubMed ID: 27141060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension.
    Sotozawa M; Kinguchi S; Wakui H; Azushima K; Funakoshi K; Nakajima W; Miyazaki T; Takahashi T; Tamura K
    Hypertens Res; 2024 Jan; 47(1):67-77. PubMed ID: 37884662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.
    Kamat NV; Thabet SR; Xiao L; Saleh MA; Kirabo A; Madhur MS; Delpire E; Harrison DG; McDonough AA
    Hypertension; 2015 Mar; 65(3):569-76. PubMed ID: 25601932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ATRAP in adipocytes and negative regulation by beta-adrenergic stimulation of JAK/STAT.
    Westphal S; Perwitz N; Iwen KA; Kraus D; Schick R; Fasshauer M; Klein J
    Horm Metab Res; 2008 Mar; 40(3):165-71. PubMed ID: 18236361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II type 1 receptor-associated protein: a novel modulator of angiotensin II actions in the nephron.
    Giani JF; Fuchs S; Gonzalez-Villalobos RA
    Hypertension; 2013 Jun; 61(6):1150-2. PubMed ID: 23529171
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain.
    Taguchi S; Azushima K; Yamaji T; Suzuki T; Abe E; Tanaka S; Hirota K; Tsukamoto S; Morita R; Kobayashi R; Kinguchi S; Yamashita A; Wakui H; Tamura K
    Hypertens Res; 2024 Jan; 47(1):55-66. PubMed ID: 37957242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy.
    Tsukuda K; Mogi M; Iwanami J; Min LJ; Jing F; Ohshima K; Horiuchi M
    J Am Soc Hypertens; 2012; 6(5):324-30. PubMed ID: 22951100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
    J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension.
    Chen D; Stegbauer J; Sparks MA; Kohan D; Griffiths R; Herrera M; Gurley SB; Coffman TM
    Hypertension; 2016 Jun; 67(6):1291-7. PubMed ID: 27141055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
    Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S
    Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney.
    Guo DF; Chenier I; Lavoie JL; Chan JS; Hamet P; Tremblay J; Chen XM; Wang DH; Inagami T
    Hypertension; 2006 Sep; 48(3):453-9. PubMed ID: 16801480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice.
    Prieto MC; Reverte V; Mamenko M; Kuczeriszka M; Veiras LC; Rosales CB; McLellan M; Gentile O; Jensen VB; Ichihara A; McDonough AA; Pochynyuk OM; Gonzalez AA
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1243-F1253. PubMed ID: 28814438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue.
    Ohki K; Wakui H; Kishio N; Azushima K; Uneda K; Haku S; Kobayashi R; Haruhara K; Kinguchi S; Yamaji T; Yamada T; Minegishi S; Ishigami T; Toya Y; Yamashita A; Imajo K; Nakajima A; Kato I; Ohashi K; Tamura K
    Sci Rep; 2018 Feb; 8(1):2846. PubMed ID: 29434287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiology of novel AT1 receptor-binding molecule, ATRAP].
    Wakui H; Tamura K
    Nihon Rinsho; 2012 Sep; 70(9):1499-503. PubMed ID: 23012794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal NOXA1/NOX1 Signaling Regulates Epithelial Sodium Channel and Sodium Retention in Angiotensin II-induced Hypertension.
    Vendrov AE; Stevenson MD; Lozhkin A; Hayami T; Holland NA; Yang X; Moss N; Pan H; Wickline SA; Stockand JD; Runge MS; Madamanchi NR; Arendshorst WJ
    Antioxid Redox Signal; 2022 Mar; 36(7-9):550-566. PubMed ID: 34714114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.